L
LENZ Therapeutics, Inc. (LENZ)
NMS – Real Time Price. Currency in USD
5.82
+0.31 (5.63%)
At close: Jun 26, 2026, 4:00 PM EDT
5.85
+0.03 (0.52%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
5.82
+0.31 (5.63%)
At close: Jun 26, 2026, 4:00 PM EDT
5.85
+0.03 (0.52%)
After-hours: Jun 26, 2026, 7:50 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 10.40 | 6.05 | 10 | |
| Quick ratio | 10.26 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | 19M | 21M |
| Gross Profit | -8M | -15K | -58K | 18M | 19M |
| Operating Income | -106M | -72M | -59M | -91M | -118M |
| Net Income | -101M | -70M | -50M | -82M | -109M |
| EBITDA | -97M | -72M | -59M | -91M | -118M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -50.25 | -101.71 | 1.0 |
| Next quarter | -44.6 | -72.66 | 1.0 |
| Current year | -0.29 | -60.03 | 1.0 |
| Next year | 239 | 23.95 | 10 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 19.71 | -15.57 | -13.78 | -1.61 | 3.0 |
| Y/Y | 999 | -183.79 | -149.05 | -107.92 | 3.3 |
| 3y average | 999 | -1.78 | 28.7 | 6.7 | 6.5 |
| 5y average | 999 | -10.32 | 27.75 | -102.4 | 5.5 |
| Weighted average score | 4.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $24.8M significantly exceed its total debt $673.0K, ensuring strong financial flexibility
Total current assets $268.4M exceed Total current liabilities $25.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$33.6M limits the company's ability to reinvest or pay down debt